ESCMID Conference on Reviving Old Antibiotics
22 - 24 October 2014, Vienna, Austria
Final Scientific Programme
Download the pdf version of the Final Programme here.
Wednesday, 22 October 2014
08:30 - 10:10 h: Setting the sceneChairs: Murat Akova & Ursula Theuretzbacher | ||
---|---|---|
08:30 - 08:40 | Welcome, introduction, opening of the conference | Murat Akova, Turkey |
08:40 - 09:10 | Reviving old antibiotics - a public health need | Dominique L. Monnet, ECDC |
09:10 - 09:40 | Usage of old antibiotics now and in the future | Johan W. Mouton, Netherlands |
09:40 - 10:10 | Ethical dilemmas when using old antibiotics | Leonard Leibovici, Israel |
10:30 - 12:30 h: Optimisation of therapy - general principlesChairs: Alasdair Mac Gowan & Keith Kaye | ||
---|---|---|
10:30 - 11:00 | Translational basic research for old antibiotics: What is lacking? | Alasdair MacGowan, United Kingdom |
11:00 - 11:30 | Optimisation of dosing regimens, dosing in special populations, duration of therapy | Jason Roberts, Australia |
11:30 - 12:00 | Optimised usage to prevent emergence of resistance and co-selection processes | Vincent H. Tam, United States |
12:00 - 12:30 | Combination therapy - The solution to all problems? | Keith Kaye, United States |
13:45 - 15:25 h: Optimisation of therapy in Gram-negative infectionsChairs: Roger Nation & Françoise Van Bambeke | ||
---|---|---|
13:45 - 14:00 | Temocillin | Françoise van Bambeke, Belgium |
14:00 - 14:15 | Fosfomycin iv | Matthew E. Falagas, Greece |
14:15 - 14:30 | Fosfomycin Trometamol | Angela Huttner, Switzerland |
14:30 - 14:45 | Nitrofurantoin | Anouk E. Muller, Netherlands |
14:45 - 15:00 | Mecillinam | Niels Frimodt-Møller, Denmark |
15:00 - 15:15 | Chloramphenicol | Noa Eliakim, Israel |
15:15 - 15:25 | Discussion |
15:45 - 17:10 h: Optimisation and individualisation of therapyChairs: Niels Frimodt-Møller & Angela Huttner | ||
---|---|---|
15:45 - 16:10 | Colistin | Roger Nation, Australia |
16:10 - 16:30 | TDM of old antibiotics - Colistin | William Couet, France |
16:30 - 16:40 | Discussion | |
16:40 - 17:10 | Clinical decision making - strategies for individual patients | George L. Daikos, Greece |
17:10 - 17:30 | Summary of the first day |
Thursday, 23 October 2014
08:30 - 10:00 h: Extending the life of old antibioticsChairs: Inge C. Gyssens & Mical Paul | ||
---|---|---|
08:30 - 09:00 | Resistance epidemiology and trends in old antibiotics | Christian G. Giske, Sweden |
09:00 - 09:30 | Impact of resistance on bacteria and epidemiological implications | Dan Andersson, Sweden |
09:30 - 10:00 | Stewardship aspects for last resort antibiotics | Inge C. Gyssens, Netherlands |
10:30 - 12:00 h: Clinical trialsChairs: Leonard Leibovici & John D. Turnidge | ||
---|---|---|
10:30 - 11:00 | How do you “re-develop” an old antibiotic: experience from AIDA | Ursula Theuretzbacher, Austria |
11:00 - 11:30 | Strength and limitations of industry vs. academic randomised controlled trials | Pierre-Francois Laterre, Belgium |
11:30 - 12:00 | Observational studies vs. randomised controlled trials | Mical Paul, Israel |
13:00 - 15:00 h: Breakpoints and susceptibility testingChairs: Johan Mouton & Rafael Cantón | ||
---|---|---|
13:00 - 13:30 | ECOFFs for the early detection of resistance development | Gunnar Kahlmeter, Sweden |
13:30 - 14:00 | Susceptibility testing issues with old antibiotics | John D. Turnidge, Australia |
14:00 - 14:30 | Drawbacks of available breakpoints | Rafael Cantón Moreno, Spain |
14:30 - 15:00 | Correlations of clinical outcomes and antimicrobial susceptibility testing result | Alex Soriano, Spain |
15:30 - 17:05 h: Regulating and communicating new knowledgeChairs: Gunnar Kahlmeter & Christian G. Giske | ||
---|---|---|
15:30 - 15:55 | Re-evaluating and revising of existing indications | Mair Powell, United Kingdom |
15:55 - 16:20 | Keeping up-to-date, regulatory issues: EMA | Radu Botgros, United Kingdom |
16:20 - 16:40 | Dealing with old drugs - the industry's perspective | Holger von Fircks, Sweden |
16:40 - 17:05 | Organising and communicating changesof knowledge to the medical communicty | Otto Cars, Sweden |
17:20 - 17:50 h: Late breaker presentations: national and international actionsChair: Otto Cars | ||
---|---|---|
17:20- 17:30 | MSF: relevance of old antibiotics in developing countries | Christophe Perrin, Switzerland |
17:30- 17:40 | WHO | Charles Penn, Switzerland |
17:40- 17:50 | Governmental action - example Sweden | Charlotta Edlund, Sweden |
Friday, 24 October 2014
08:30 - 10:30 h: Round table discussionChairs: Ursula Theuretzbacher & Gunnar Kahlmeter | |
---|---|
Within preceding sessions key issues will be identified to be discussed among panel members and the audience. Solved and unsolved problems with old antibiotics in the following areas:
|
10:50 - 12:20 h: Consensus sessionChairs: Ursula Theuretzbacher & Gunnar Kahlmeter | |
---|---|
Discuss and agree on need for action. Input from the audience will be highly appreciated! |
12:20 - 12:30 h: Conclusion and closing of the conference | |
---|---|